MiR-185-3p/Liver-Type Phosphofructokinase Alleviates Erlotinib Resistance of Lung Cancer Cells by Inhibiting Epidermal Growth Factor Receptor Alternative Pathway. Here, EGFR is linked to lung carcinoma.